{"transactions":[{"id":774507,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T18:35:50.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":14058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027."}],"balance_after":14058,"derivative":{"exercise_price":25.8,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":14058},"source":{"system":"sec-edgar","filing":"0001380022-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000138002226000002/ownership.xml","form_type":"4"}},{"id":774506,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T18:35:50.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":7751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027."}],"balance_after":40441,"source":{"system":"sec-edgar","filing":"0001380022-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000138002226000002/ownership.xml","form_type":"4"}},{"id":1142124,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-19T18:32:48.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":10787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026."}],"balance_after":10787,"derivative":{"exercise_price":34.84,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":10787},"source":{"system":"sec-edgar","filing":"0000950170-25-074665","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000095017025074665/ownership.xml","form_type":"4"}},{"id":1142123,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T18:32:48.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":5740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026."}],"balance_after":32690,"source":{"system":"sec-edgar","filing":"0000950170-25-074665","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000095017025074665/ownership.xml","form_type":"4"}},{"id":1472892,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T14:24:21.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025."}],"balance_after":9900,"derivative":{"exercise_price":37.42,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":9900},"source":{"system":"sec-edgar","filing":"0000950170-24-075487","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000095017024075487/ownership.xml","form_type":"4"}},{"id":1472891,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T14:24:21.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":5345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025."}],"balance_after":26950,"source":{"system":"sec-edgar","filing":"0000950170-24-075487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000095017024075487/ownership.xml","form_type":"4"}},{"id":1860166,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T14:30:09.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":7110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024."}],"balance_after":7110,"derivative":{"exercise_price":51.82,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":7110},"source":{"system":"sec-edgar","filing":"0001209191-23-035688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919123035688/doc4.xml","form_type":"4"}},{"id":1860165,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T14:30:09.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":3860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024."}],"balance_after":21605,"source":{"system":"sec-edgar","filing":"0001209191-23-035688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919123035688/doc4.xml","form_type":"4"}},{"id":2220017,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-28T13:51:07.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":6245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023."}],"balance_after":6245,"derivative":{"exercise_price":60.57,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":6245},"source":{"system":"sec-edgar","filing":"0001209191-22-039565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919122039565/doc4.xml","form_type":"4"}},{"id":2220016,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-28T13:51:07.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023."}],"balance_after":17745,"source":{"system":"sec-edgar","filing":"0001209191-22-039565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919122039565/doc4.xml","form_type":"4"}},{"id":2653148,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-28T18:23:35.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022."}],"balance_after":4125,"derivative":{"exercise_price":93.2,"expiration_date":"2031-06-24","underlying":"Common Stock","underlying_shares":4125},"source":{"system":"sec-edgar","filing":"0001209191-21-043538","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919121043538/doc4.xml","form_type":"4"}},{"id":2653147,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T18:23:35.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":2145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022."}],"balance_after":14445,"source":{"system":"sec-edgar","filing":"0001209191-21-043538","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919121043538/doc4.xml","form_type":"4"}},{"id":3096381,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-30T13:13:42.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021."}],"balance_after":4250,"derivative":{"exercise_price":76.58,"expiration_date":"2030-06-26","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001209191-20-039407","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919120039407/doc4.xml","form_type":"4"}},{"id":3096380,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T13:13:42.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":2550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021"}],"balance_after":12300,"source":{"system":"sec-edgar","filing":"0001209191-20-039407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919120039407/doc4.xml","form_type":"4"}},{"id":3490948,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T16:46:25.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 11, 2020."}],"balance_after":5000,"derivative":{"exercise_price":58.74,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-036816","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919119036816/doc4.xml","form_type":"4"}},{"id":3490947,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T16:46:25.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 11, 2020."}],"balance_after":9750,"source":{"system":"sec-edgar","filing":"0001209191-19-036816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919119036816/doc4.xml","form_type":"4"}},{"id":3886943,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-20T18:12:29.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 19, 2019."}],"balance_after":5000,"derivative":{"exercise_price":80.69,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-038857","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919118038857/doc4.xml","form_type":"4"}},{"id":3886942,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-20T18:12:29.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 19, 2019."}],"balance_after":6750,"source":{"system":"sec-edgar","filing":"0001209191-18-038857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919118038857/doc4.xml","form_type":"4"}},{"id":4184578,"issuer":{"id":157016,"kind":"organization","name":"Orexigen Therapeutics, Inc.","symbol":"OREXQ"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2017-10-17T19:16:35.000Z","date":"2017-10-13","kind":"grant","acquired":true,"shares":252000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an award of restricted stock units (\"RSUs\"), each representing a contingent right to receive a share of the issuer's common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the RSUs will vest on each of the first four (4) anniversaries of February 3, 2018 (each, a \"Vesting Date\"), subject to the reporting person's continued eigibility on each applicable Vesting Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Twenty-five percent (25%) of the RSUs will vest on each of the first four (4) anniversaries of February 3, 2018 (each, a \"Vesting Date\"), subject to the reporting person's continued eigibility on each applicable Vesting Date."}],"balance_after":252000,"derivative":{"underlying":"Common Stock","underlying_shares":252000},"source":{"system":"sec-edgar","filing":"0001209191-17-057217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919117057217/doc4.xml","form_type":"4"}},{"id":4274289,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-06-22T19:26:25.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 22, 2018."}],"balance_after":3750,"derivative":{"exercise_price":65.66,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-17-041474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919117041474/doc4.xml","form_type":"4"}},{"id":4274288,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-22T19:26:25.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 22, 2018."}],"balance_after":3750,"source":{"system":"sec-edgar","filing":"0001209191-17-041474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919117041474/doc4.xml","form_type":"4"}},{"id":4295258,"issuer":{"id":157016,"kind":"organization","name":"Orexigen Therapeutics, Inc.","symbol":"OREXQ"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2017-06-02T16:55:26.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":626,"price":1.55,"value":970.3,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Shares acquired under Issuer's 2013 Employee Stock Purchase Plan."}],"balance_after":8356,"source":{"system":"sec-edgar","filing":"0001209191-17-037346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919117037346/doc4.xml","form_type":"4"}},{"id":4463690,"issuer":{"id":157016,"kind":"organization","name":"Orexigen Therapeutics, Inc.","symbol":"OREXQ"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option","published_at":"2017-02-07T06:51:00.000Z","date":"2017-02-03","kind":"grant","acquired":true,"shares":157500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each month following 2/3/2017, so that all of the shares of the stock subject to the option shall be vested on 2/3/2021, subject to the Reporting Person's continued service relationship (whether as an employee, director or consultant) with the Issuer or any parent or subsidiary on each such date, as set forth in the applicable stock option grant notice and stock option agreement for such Reporting Person."}],"balance_after":157500,"derivative":{"exercise_price":15,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001209191-17-008202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919117008202/doc4.xml","form_type":"4"}},{"id":4463689,"issuer":{"id":157016,"kind":"organization","name":"Orexigen Therapeutics, Inc.","symbol":"OREXQ"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option","published_at":"2017-02-07T06:51:00.000Z","date":"2017-02-03","kind":"grant","acquired":true,"shares":315000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each month following 2/3/2017, so that all of the shares of the stock subject to the option shall be vested on 2/3/2021, subject to the Reporting Person's continued service relationship (whether as an employee, director or consultant) with the Issuer or any parent or subsidiary on each such date, as set forth in the applicable stock option grant notice and stock option agreement for such Reporting Person."}],"balance_after":315000,"derivative":{"exercise_price":4.1,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":315000},"source":{"system":"sec-edgar","filing":"0001209191-17-008202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919117008202/doc4.xml","form_type":"4"}},{"id":4534911,"issuer":{"id":157016,"kind":"organization","name":"Orexigen Therapeutics, Inc.","symbol":"OREXQ"},"owners":[{"id":46351,"kind":"person","name":"NARACHI MICHAEL","position":1,"cik":"0001380022","reported_name":"NARACHI MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2016-12-02T17:11:33.000Z","date":"2016-11-30","kind":"grant","acquired":true,"shares":802,"price":1.67,"value":1339.34,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Shares acquired under Issuer's 2013 Employee Stock Purchase Plan."}],"balance_after":6312,"source":{"system":"sec-edgar","filing":"0001209191-16-153095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380022/000120919116153095/doc4.xml","form_type":"4"}}]}